Aptorum Group Limited has entered into agreements for a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, raising gross proceeds of $2 million. In a concurrent private placement, the company will also issue unregistered warrants to purchase up to 2,000,000 Class A ordinary shares at an exercise price of $2.00 per share, which could generate up to an additional $4 million if fully exercised. The net proceeds from the offering are intended to fund expenses related to the previously announced merger agreement between Aptorum and DiamiR Biosciences Corp., as well as for general working capital for both companies while the merger process continues. The merger is still subject to certain conditions, including approval by Aptorum's shareholders.